Ostrich Pharmaceuticals Private Limited
About Ostrich Pharmaceuticals Private Limited
Data last updated:
Ostrich Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 24 November 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74900DL2011PTC227898. Its GSTIN is 37AABCO6291P1ZQ (Andhra Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Shaik Mastan (Managing Director) and Ramesh Reddy Guntaka.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Rz – 1/63 B Gali No. 3 Tughlakabad Extension, New Delhi, Delhi, India – 110019.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.63 Cr, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹16.01 Lakh (net margin 2.4%) and EBITDA of ₹26.58 Lakh (EBITDA margin 4%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 10% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Ostrich Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressRz – 1/63 B Gali No. 3 Tughlakabad Extension, New Delhi, Delhi, India – 110019
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Ostrich Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ostrich Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ostrich Pharmaceuticals Private Limited, buy the company report.
Financials of Ostrich Pharmaceuticals Private Limited
FY 2025 filings availableOstrich Pharmaceuticals Private Limited reported revenue of ₹6.63 Cr (up 15% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 15% growth in the latest year. EBITDA fell 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹26.58 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹16.01 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4% | ||||
| Net Profit Margin | 2.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ostrich Pharmaceuticals Private Limited, buy the company report.
Board of directors of Ostrich Pharmaceuticals Private Limited
Ostrich Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ramesh Reddy Guntaka | Director | 24 Nov 2011 | 14 Years 11 Months | Current |
| Gogulamudi Upendra Reddy Also directs: Rivaan Healthcare Private Limited, Arki Medtech Private Limited | Director | 24 Nov 2011 | 14 Years 11 Months | Current |
| Shaik Mastan | Managing Director | 24 Nov 2011 | 14 Years 11 Months | Current |
Peer comparison
Ostrich Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Garle Impex Private Limited | ₹6.66 Cr (FY 2025) | 15.0% | Gwalior, Madhya Pradesh, India | |||
| Raghava Diagnostic Services Private Limited | ₹6.64 Cr (FY 2025) | -74.0% | Bengaluru, Karnataka, India | |||
| Ostrich Pharmaceuticals Private Limitedthis company | ₹6.63 Cr (FY 2025) | ₹16.01 Lakh | 2.4% | 15.0% | New Delhi, Delhi, India | |
| Bilberry Pharmaceuticals Private Limited | ₹6.62 Cr (FY 2024) | 67.0% | Indore, Madhya Pradesh, India | |||
| Everest Distributions Private Limited | ₹6.61 Cr (FY 2025) | 18.0% | New Delhi, Delhi, India | |||
| Anil Medicos Pvt Ltd | ₹6.61 Cr (FY 2025) | 13.0% | Haryana, India |
To see the full peer comparison of Ostrich Pharmaceuticals Private Limited, buy the company report.
Auditor
Ostrich Pharmaceuticals Private Limited is audited by KONDEPATI & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KONDEPATI & CO | FY 2021 | 012912S |
Shareholding
The shareholding of Ostrich Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Ostrich Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ostrich Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ostrich Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ostrich Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AABCO6291P1ZQ | Andhra Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ostrich Pharmaceuticals Private Limited, buy the company report.
Recent activity
Ostrich Pharmaceuticals Private Limited has 4 board changes on record since 2011: 3 appointments and 1 cessation. The latest: Shaik Mastan ceased to be Director on 02 Mar 2012.
Frequently asked questions
Ostrich Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 24 November 2011 (15+ years old) and is registered under CIN U74900DL2011PTC227898.
Ostrich Pharmaceuticals has 3 current directors:
- Shaik Mastan - Managing Director
- Ramesh Reddy Guntaka - Director
- Gogulamudi Upendra Reddy - Director
The latest financial statements of Ostrich Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Ostrich Pharmaceuticals is 37AABCO6291P1ZQ, registered in Andhra Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Ostrich Pharmaceuticals is U74900DL2011PTC227898. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ostrich Pharmaceuticals was incorporated on 24 November 2011, making it 15+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Ostrich Pharmaceuticals by revenue are Garle Impex Private Limited, Raghava Diagnostic Services Private Limited, Bilberry Pharmaceuticals Private Limited, Everest Distributions Private Limited, Anil Medicos Pvt Ltd, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Shaik Mastan ceased to be Director on 02 Mar 2012. Gogulamudi Upendra Reddy was appointed as Director on 24 Nov 2011. Ramesh Reddy Guntaka was appointed as Director on 24 Nov 2011. Ostrich Pharmaceuticals has 4 board changes on record in total.
The registered office of Ostrich Pharmaceuticals is at Rz – 163 B Gali No. 3 Tughlakabad Extension, New Delhi, Delhi, India – 110019.
Ostrich Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Ostrich Pharmaceuticals is compliant as of 23 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
